UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nitinol Stent Implantation in Long Superficial Femoral Artery Lesions: 12-Month Results of the DURABILITY I Study

Journal of endovascular therapy, 2009-06, Vol.16 (3), p.261-269

2009

Volltextzugriff (PDF)

Abciximab, Eptifibatide, and Tirofiban Exhibit Dose-dependent Potencies to Dissolve Platelet Aggregates

Journal of cardiovascular pharmacology, 2003-04, Vol.41 (4), p.586-592

2003

Volltextzugriff (PDF)

Coronary Stent Thrombosis Related to Aspirin Resistance: What are the Underlying Mechanisms?

Journal of interventional cardiology, 2006-12, Vol.19 (6), p.507-509

2006

Volltextzugriff (PDF)

Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury

Arteriosclerosis, thrombosis, and vascular biology, 2000-07, Vol.20 (7), p.1745-1752

2000

Volltextzugriff (PDF)

Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal

Circulation (New York, N.Y.), 1998-03, Vol.97 (11), p.1071-1078

1998

Volltextzugriff (PDF)

Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease

Thrombosis and haemostasis, 1999, Vol.82 Suppl 1 (S 01), p.14-18

1999

Volltextzugriff (PDF)

One-Year Follow-up after Implantation of the EverFlex Nitinol Stent in Long Lesions of the Superficial Femoral Artery

Angiology, 2009-02, Vol.60 (1), p.31-35

Ruef, Johannes

2009

Volltextzugriff (PDF)

Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches

Thrombosis and haemostasis, 1999, Vol.82 Suppl 1 (S 01), p.32-37

1999

Volltextzugriff (PDF)

Differential regulation of protease activated receptor-1 and tissue plasminogen activator expression by shear stress in vascular smooth muscle cells

Circulation research, 1998-11, Vol.83 (10), p.1027-1034

1998

Volltextzugriff (PDF)

Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study

Cardiovascular drugs and therapy, 2024-02, Vol.38 (1), p.119-129

2024

Volltextzugriff (PDF)

Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis

Thrombosis and haemostasis, 1999, Vol.82 Suppl 1 (S 01), p.38-43

1999

Volltextzugriff (PDF)

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism

Platelets (Edinburgh), 2006-05, Vol.17 (3), p.163-169

2006

Volltextzugriff (PDF)

Closure of guide wire‐induced coronary artery perforation with a two‐component fibrin glue

Catheterization and cardiovascular interventions, 2007-08, Vol.70 (2), p.237-240

2007

Volltextzugriff (PDF)

Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction

Thrombosis and haemostasis, 1998-12, Vol.80 (6), p.881-886

1998

Volltextzugriff (PDF)

Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells

Thrombosis and haemostasis, 2001-11, Vol.86 (5), p.1305-1313

2001

Volltextzugriff (PDF)

Increased Restenosis Rates 12 Months After Coronary Implantation of the Sirolimus‐Eluting YUKON‐Choice Stent Compared to the Paclitaxel‐Eluting TAXUS Stent

Clinical cardiology (Mahwah, N.J.), 2010-04, Vol.33 (4), p.E33-E38

2010

Volltextzugriff (PDF)

Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions

Catheterization and cardiovascular interventions, 2008-02, Vol.71 (3), p.333-339

2008

Volltextzugriff (PDF)

Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo

The Journal of biological chemistry, 1999-07, Vol.274 (28), p.19814

1999

Volltextzugriff (PDF)

Differential transcriptional regulation of the human thrombin receptor gene by the Sp family of transcription factors in human endothelial cells

Biochemical journal, 1998-03, Vol.330 ( Pt 3) (3), p.1469-1474

1998

Volltextzugriff (PDF)

Antikoagulation - Bewährtes und neue Trends im Überblick

Der Klinikarzt, 2003, Vol.32 (8), p.258-264

Ruef, J.

2003

Volltextzugriff (PDF)

A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregation

Thrombosis and haemostasis, 1999-07, Vol.82 (1), p.109-114

1999

Volltextzugriff (PDF)

Ablation of atrial flutter by the femoral approach in the absence of inferior vena cava

Europace (London, England), 2007-11, Vol.9 (11), p.1073-1074

2007

Volltextzugriff (PDF)

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA1/2 polymorphism

Platelets (Edinburgh), 2006, Vol.17 (3), p.163-169

2006

Volltextzugriff (PDF)

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA 1/2 polymorphism

Platelets (Edinburgh), 2006-01, Vol.17 (3), p.163-169

2006

Volltextzugriff (PDF)

The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation

Platelets (Edinburgh), 2008-01, Vol.19 (5), p.359-364

2008

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(80)
Deutsch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nitinol Stent Implantation in Long Superficial Femoral Artery Lesions: 12-Month Results of the DURABILITY I Study

Abciximab, Eptifibatide, and Tirofiban Exhibit Dose-dependent Potencies to Dissolve Platelet Aggregates

Coronary Stent Thrombosis Related to Aspirin Resistance: What are the Underlying Mechanisms?

Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury

Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal

Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease

One-Year Follow-up after Implantation of the EverFlex Nitinol Stent in Long Lesions of the Superficial Femoral Artery

Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches

Differential regulation of protease activated receptor-1 and tissue plasminogen activator expression by shear stress in vascular smooth muscle cells

Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study

Soluble vascular cell adhesion molecule-1 (VCAM-1) as potential marker of atherosclerosis

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism

Closure of guide wire‐induced coronary artery perforation with a two‐component fibrin glue

Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction

Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells

Increased Restenosis Rates 12 Months After Coronary Implantation of the Sirolimus‐Eluting YUKON‐Choice Stent Compared to the Paclitaxel‐Eluting TAXUS Stent

Comparison of a polymer-free rapamycin-eluting stent (YUKON) with a polymer-based paclitaxel-eluting stent (TAXUS) in real-world coronary artery lesions

Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo

Differential transcriptional regulation of the human thrombin receptor gene by the Sp family of transcription factors in human endothelial cells

Antikoagulation - Bewährtes und neue Trends im Überblick

A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregation

Ablation of atrial flutter by the femoral approach in the absence of inferior vena cava

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA1/2 polymorphism

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA 1/2 polymorphism

The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation

Suchergebnisse filtern